VJHemOnc is committed to improving our service to you

COMy 2019 | Second interim analysis of the EMN02 trial

VJHemOnc is committed to improving our service to you

Michele Cavo

Michele Cavo, MD, of Bologna University School of Medicine, Bologna, Italy, discusses the second interim analysis of the EMN02 trial (NCT01208766), which is the largest academic trial so far that aims to compare upfront transplant vs. standard dosing and consolidation vs. no consolidation for multiple myeloma. This interview was recorded at the Controversies in Multiple Myeloma (COMy) 2019 meeting held in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter